Does CARFILZOMIB Cause Rash maculo-papular? 59 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Rash maculo-papular have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.3% of all adverse event reports for CARFILZOMIB.
59
Reports of Rash maculo-papular with CARFILZOMIB
0.3%
of all CARFILZOMIB reports
6
Deaths
36
Hospitalizations
How Dangerous Is Rash maculo-papular From CARFILZOMIB?
Of the 59 reports, 6 (10.2%) resulted in death, 36 (61.0%) required hospitalization, and 7 (11.9%) were considered life-threatening.
Is Rash maculo-papular Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Rash maculo-papular?
SULFAMETHOXAZOLE\TRIMETHOPRIM (935)
AMOXICILLIN (871)
VANCOMYCIN (642)
PIPERACILLIN\TAZOBACTAM (629)
PANTOPRAZOLE (589)
LAMOTRIGINE (568)
ALLOPURINOL (550)
CARBOPLATIN (529)
ACETAMINOPHEN (499)
CLINDAMYCIN (484)
Which CARFILZOMIB Alternatives Have Lower Rash maculo-papular Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL